Search research articles
Contact Us
Filters
Showing results (541-550 of 564) with videos related to
Page
of 57
Sort By:
European Urology Focus
|
July 30, 2017
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study
Andrea Necchi, Gregory R Pond, Marc C Smaldone, et al.
European Urology
|
October 12, 2016
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
Andrea Necchi, Guru Sonpavde, Salvatore Lo Vullo, et al.
Nature
|
October 9, 2024
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution
Duy D Nguyen, William F Hooper, Weisi Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
Emanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
European Urology Oncology
|
December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer
Jacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I Scher, Michael J Morris, Walter M Stadler, et al.
European Urology Focus
|
July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
Andrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
Lancet (London, England)
|
September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
Daniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2015
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, et al.
Page
of 57
Search research articles
Search
Showing results (541-550 of 564) with videos related to
Sort By:
Page
of 57
European Urology Focus
|
July 30, 2017
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study
Andrea Necchi, Gregory R Pond, Marc C Smaldone, et al.
European Urology
|
October 12, 2016
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
Andrea Necchi, Guru Sonpavde, Salvatore Lo Vullo, et al.
Nature
|
October 9, 2024
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution
Duy D Nguyen, William F Hooper, Weisi Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 2, 2024
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
Emanuel Bührer, David D'Haese, Gedske Daugaard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
European Urology Oncology
|
December 10, 2023
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer
Jacob J Orme, Fadi Taza, Navonil De Sarkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Howard I Scher, Michael J Morris, Walter M Stadler, et al.
European Urology Focus
|
July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
Andrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
Lancet (London, England)
|
September 17, 2017
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
Daniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 5, 2015
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, et al.
Page
of 57